A CNBC reporter since 1990, Bob Pisani has covered Wall Street and the stock market for nearly 20 years. Pisani covered the real estate market for CNBC from 1990-1995, then moved on to cover corporate management issues before becoming Stocks Correspondent in 1997.
In addition to covering the global stock market, he also covers initial public offerings (IPOs), exchange-traded funds (ETFs) and financial market structure for CNBC.
In 2013, he won Third Place in the National Headliner Awards in the Business and Consumer Reporting category for his documentary on the diamond business, "The Diamond Rush."
In 2014, Pisani was honored with a Recognition Award from the Market Technicians Association for "steadfast efforts to integrate technical analysis into financial decision making, journalism and reporting."
Prior to joining CNBC, Pisani co-authored "Investing in Land: How to Be a Successful Developer." He and his father taught a course in real estate development at the Wharton School of Business at the University of Pennsylvania from 1987-1992. Pisani learned the real estate business from his father, Ralph Pisani, a retired real estate developer.
Follow Bob Pisani on Twitter @BobPisani.
OK, so Wall Street is back to work, and of course everyone is saying nobody's going to be around! Light volume. Well, maybe. Many will undoubtedly take off. But don't kid yourself: If there's money to be made, there's always going to be people around.
Wall Street is open, but who will be on Wall Street? This is already one of the biggest vacation weeks of the year. Faced with the possibility of a difficult commute to work, many on Wall Street may simply opt to stay home.
It's happened before: on 9/11 (a Tuesday), SEC Chairman Harvey Pitt did halt trading the following Wednesday through Friday, and reopened Monday, September 17.
The three-month London Interbank Offered Rate — Libor — is around the highest level it's been since May 2009.
Portugal's bank recapitalization plan is "another big step towards the stabilization of the Portuguese financial system," the finance minister says.
Shares of Teva Pharmaceuticals fell as much as 6 percent after the U.S. Patent Office invalidated two of the company's patents.